The request to the Federal Institute for Drugs and Medical Devices (BfArM) goes against a landmark judgment in 2017 that ruled seriously ill patients in extreme and exceptional circumstances should not be denied access to euthanasia drugs. In view of “fundamental and far-reaching questions, particularly constitutional questions … It cannot be the task of the state to actively support suicidal acts through the official, administrative approval of the acquisition of the specific suicide agent.
The Ministry of Health State Secretary Lutz Stroppe wrote in a letter seen by German news outlets Der Spiegel, and “This is not compatible with the purpose of the Narcotics Act to ensure the necessary medical care of the population. A suicide cannot be considered therapy,” the letter continued. Some 108 patients have submitted applications for euthanasia drugs since the March 2017 ruling and at least 20 have already died, reported citing BfArM figures. (See HERE)